Repair of the postmenstrual endometrium presents a unique opportunity to examine nonscarring repair in an adult tissue. We aimed to characterize and determine the importance of extracellular matrix (ECM) dynamics in cell migration during endometrial repair. Utilizing an in vivo mouse model of postmenstrual repair and an in vitro model of human endometrial re-epithelialization, we determined the dynamic changes in expression of ECM and related factors in both models by array analysis of repairing areas. We also validated expression of integrins, growth factors, protease inhibitors, basement membrane, and adhesion molecules in vitro and in both mouse and human repairing endometrium by quantitative RT-PCR and immunohistochemical studies. Finally, we determined the functional importance of integrin-fibronectin interactions and matrix metalloprotease (MMP)-facilitated cell movement during re-epithelialization and propose a model for cell locomotion during postmenstrual repair. These data demonstrated the dynamic expression and functional importance of ECM interactions in endometrial repair, which may be important for scarfree repair.
INTRODUCTION
Postmenstrual repair of the endometrium is a fascinating phenomenon, which represents the only example of cyclic scar-free repair in adult human tissue. While most tissues repair with some degree of scarring, the endometrium exhibits rapid cyclic scar-free re-epithelialization [1] . Repair after wounding in any tissue is essential for tissue homeostasis [2] . In the skin, the process of wound repair is well characterized and is associated with initial recruitment of inflammatory cells, formation of a fibrin clot and then granulation tissue, and finally restoration of the wounded tissue with scar formation [2, 3] . The only true models of scar-free repair are observed in the first and early second trimester fetus, regeneration of limbs in amphibians, and postmenstrual endometrial repair in menstruating species [1] [2] [3] [4] [5] [6] . It is therefore tempting to speculate that repair in the endometrium may proceed by a mechanism similar to that observed in other scar-free models. Early pregnancy fetuses and urodele amphibians are proposed to experience scar-free repair due to their inability to mount an extensive inflammatory response to wounding [5, 7] . In contrast, menstruation is an intensely inflammatory event, with menstrual shedding and endometrial repair occurring concurrently [8] [9] [10] . Thus, the endometrium repairs in a highly inflammatory environment and requires rapid repair to stop bleeding and restore a large area of tissue.
What then is unique about the endometrium and how does it repair? This is difficult to answer from examination of menstrual endometrial biopsies, as shedding and repair occur concurrently. It is, therefore, almost impossible to sample a ''repairing'' area of menstrual endometrium. Additionally, repair proceeds at different rates in different women; repair in one woman may be complete by Day 3 of the menstrual cycle (Day 1 being the first day of menstrual bleeding), whereas in another woman, repair may not be complete until Day 6 [10] . Again, this makes study of clinical samples difficult, requiring careful examination and classification of histological specimens. Furthermore, since menstruation occurs only in humans, some Old World primates [11, 12] , the elephant shrew [13] , and fruit bats [14, 15] , there are no readily available animal models with which to study this process.
In addition to an inflammatory response and production of growth factors, chemokines, and cytokines, dynamic changes in the extracellular matrix (ECM) are required to facilitate the locomotion of luminal epithelial cells involved in the initial stages of endometrial repair [16] . This re-epithelialization is essential to endometrial repair, cessation of menstrual bleeding, and subsequent endometrial function. Without rapid, complete re-epithelialization and accompanying vasoactive events, menstrual bleeding does not stop, and a functional endometrium cannot be regenerated in preparation for pregnancy. Indeed, postmenstrual endometrial re-epithelialization may be a rate-limiting step in endometrial growth and function.
In this study we aimed to further understand the processes involved in endometrial re-epithelialization by defining the dynamic changes in expression of ECM and related molecules during the course of endometrial repair. We utilized two models of endometrial repair, an in vitro model of reepithelialization using a human endometrial luminal epithelial cell line (ECC-1) [17] , and an in vivo mouse model in which induced shedding and repair of the endometrium allows examination of menstruation-like events at specific time points [18] . These data provide insight into the role of dynamic changes in the ECM during endometrial repair and, by comparison with other models of repair, offer some explanation as to why repair in this tissue is scar free.
MATERIALS AND METHODS

Human Tissue Collection
Human endometrial tissue biopsy samples were obtained by curettage from women of reproductive age, who were undergoing laparoscopic sterilization or assessment of tubal patency. All samples included for assessment in this study were taken from women who were known to be fertile, with no endometrial pathology. All tissue samples used for this study were collected with approval from the Southern Health human ethics committee and informed written consent from participants. Each sample was fixed in 10% buffered formalin prior to processing to paraffin blocks. Archived tissues were used for immunohistochemical studies. Cycle stage for each patient sample was determined by a pathologist who used histological examination without prior knowledge of the sample type, according to the criterion of Noyes et al. [19] , and by dating to the day on which bleeding started for menstrual samples or to the day of menstrual cycle.
Reagents
The following reagents were purchased from the sources shown: Arg-GlyAsp (RGD) and RGES peptides, doxycycline, TRI reagent, 1-bromo-2-chloropropane, 2-propanol, fibronectin antibody, 17b-estradiol, crystalline progesterone, integrin-b 1 , TIMP1, TGFB1 primers, and b-actin (Sigma Aldrich, SA, Australia); GM6001/ilomastat (Calbiochem, Merck Pty., VIC, Australia); RT 2 Profiler PCR arrays (product code PAMM-013) and oligonucleotide GEArrays (product code GA-034; SA Biosciences, Jomar Bioscience, SA, Australia); phase lock tubes (5-Prime, Quantum Scientific, QLD, Australia); power SYBR-Green Master Mix (ABI, Applied Biosystems, VIC, Australia); integrin and vascular cell adhesion molecule (VCAM) antibodies (Santa Cruz Biotechnology, Thermo Fisher Scientific, VIC, Australia); 3,3 0 -diaminobenzidine (DAB), and rabbit anti-rat and swine anti-goat biotinylated antibodies (Dako, VIC, Australia); rabbit anti-mouse neutrophil antibody (Serotec, Abacus ALS, OLD, Australia); horse anti-goat biotinylated antibody (Vector, Abacus ALS, OLD, Australia); RNAzap (Ambion, ABI, VIC, Australia); membrane slides (Palm MicroLaser Technologies AG, Burnried, Germany); and Dulbecco modified Eagle medium-F12 (DMEM-F12) and fetal calf serum (FCS; Invitrogen, VIC, Australia). The ECC-1 cells were a kind gift from Prof. Bruce Lessey (Center for Women's Medicine, Division of Reproductive Endocrinology and Infertility, Greenville Hospital System, Greenville, SC).
Endometrial Epithelial Cell Culture
ECC-1 cells were routinely maintained in a 1:1 mixture of DMEM-F12 supplemented with 1% L-glutamine, 1% penicillin and streptomycin, and 10% FCS. ECC-1 cells were chosen for these studies because they closely resemble primary human endometrial epithelial cells and are representative of the luminal epithelium [20] .
Wounding Assays
Cells were plated at 1 3 10 6 cells per well of a six-well plate or 5 3 10 4 cells per well of a 96-well plate and grown to overconfluence for 72 h. Cells were adapted to low serum conditions in DMEM-F12 containing 2% charcoalstripped FCS for 24 h before wounding by using vacuum suction through a protein electrophoresis pipette tip (BioRad). On the day of wounding, designated Day 0 (D0), cell wounds were photographed using a Motic AE31 inverted microscope and camera and Motic Images plus2.0 software (Motic Microscopy, Hong Kong). This was repeated every 24 h for up to 6 days. Medium was replaced with phosphate-buffered saline for photographing and then replaced. To assess differences in repair, the area of each cell wound was quantitated using Motic Images plus2.0 imaging software on D0 and on each subsequent day, with data expressed as percentage of repair versus D0. For each experiment, at least four wounds were assessed per individual treatment to reduce intra-assay variability, with treatments presented as mean 6 SEM of at least four separate experiments. Treatments used included RGDS and RGES, each at a final concentration of 25 lM, doxycycline at a final concentration of 0.5 lg/ml or 2.5lg/ml, or GM6001 at a final concentration of 20 lM or 25lM, with equivalent concentrations of dimethyl sulfoxide used for control wells. These doses were chosen after preliminary experiments.
Animals
Ethics approval for this project was granted by the Monash Medical Centre Animal Ethics Committee. Mice of 8-10 weeks of age were housed under standard conditions, with food and water provided ad libitum, and a constant light cycle of 12 h (lights-on from 0800-2000 h).
Mouse Model of Endometrial Breakdown and Repair
Endometrial breakdown and repair was induced in mice according to a standard protocol [18] . Briefly, under xylazine-ketamine-induced anesthesia, mice were ovariectomized 7 days before the first of three daily subcutaneous (s.c.) injections of 100 ng of 17b-estradiol in Arachis oil at 0900 h. After mice were rested for 3 days, crystalline progesterone (P) implants were inserted s.c. into the back of each mouse. Simultaneously, the mice received single injections s.c. of P and 5 ng of 17b-estradiol in Arachis oil at 0900 h on that and on the subsequent 2 days. At 1100 h on the day of final 17b-estradiol injection, 20 ll of sesame oil was injected into the lumen of the right uterine horn of each mouse. The left horn remained untreated as a control. The P implants were removed 48 h after oil injection, designated Time 0. At 24 h, the oil-treated endometrium underwent complete menstruation-like breakdown. At 36 h, the endometrium was actively repairing, with almost complete repair of the endometrial surface at 48 h. In this study, mice were killed at 36 h for laser capture microdissection or at 48 h for immunohistochemistry. Uterine horns were longitudinally fixed in OCT embedding medium before being processed for laser capture microdissection or fixed in formalin before being processed for immunohistochemistry.
Laser Capture Microdissection
Sections of mouse uteri were cut longitudinally at 20 lm, using a Leica CM1850 model cryostat at À208C. Sections were fixed in 100% acetone at À208C and stained in an ice-cold 1:100 solution of diethyl pyrocarbonatehematoxylin. Sections were dehydrated in increasing concentrations of ice-cold ethanol before they were dried and stored at À808C. Laser capture microdissection was performed to isolate the luminal epithelium and subluminal stroma by using the Palm microlaser microdissection system (Palm MicroLaser Technologies AG). At least 15 sections per horn were subject to laser capture. Tissue was captured from control and repairing uterine horns from four animals and processed as eight individual samples.
RNA Extraction
RNA was extracted from cells and laser-captured material with TRI-reagent following the manufacturer's guidelines. Briefly, cells or laser-captured tissue was homogenized in TRI-reagent, and lysates were transferred to phase lock tubes, followed by addition of 1-bromo-2-chloropropane. Samples were centrifuged to separate organic and inorganic phases, followed by transfer of the upper phase to an RNase-free tube. A solution of 2-propanol was added prior to overnight storage at À808C. RNA was precipitated by centrifugation, followed by washing of the RNA pellet in 70% ethanol and resuspension of RNA in RNase-free water. RNA concentration was assessed using a nanodrop spectrophotometer, and RNA quality was assessed using Experion RNA chips (Bio-Rad) prior to processing for array or real-time RT-PCR analysis. RNA was not found to be degraded prior to processing for array or RT-PCR.
Oligonucleotide GEArrays Results
RNA extracted from wound-healing assays in 96-well plates were pooled (n ¼ 6/time point) and subjected to pathway-focused oligonucleotide array analysis to examine expression of 115 extracellular matrix factors. Arrays were performed according to the manufacturer's guidelines (product code GA-034; SABiosciences). Briefly, an annealing mixture was prepared using 1.5 lg of RNA, followed by incubation at 708C for 10 min. cDNA was synthesized by incubation of annealing mixture with cDNA synthesis Master Mix (cDNA synthesis buffer, RNase inhibitor, cDNA synthesis enzyme) at 428C for 50 min, 758C for 5 min, followed by cooling to 378C. To prepare and amplify biotinylated cRNA, cDNA was incubated with 10 mM biotinylated uridine-5 0 -triphosphate and RNA polymerase enzyme for 16 h at 378C. The cRNA was subsequently purified by spin column filtration to remove nonreacted products. Each pathway-focused array membrane was prehybridized overnight at 608C in hybridization buffer prior to overnight hybridization with 3 lg of biotinylated cRNA at 608C. After hybridization of biotinylated cRNA, arrays were washed twice with high stringency buffers prior to detection of biotinylated RNA bound to oligonucleotide sequences spotted onto arrays utilizing CDP-Star chemiluminescence, detected on x-ray film. X-ray films were scanned at high resolution and densitometrically analyzed using GelDoc software (Bio-Rad Laboratories, Regents Park, NSW, Australia). Signals were normalized for background signal intensity. Expression patterns of ECM genes across a time course of wound repair were determined and expressed as absolute values relative to those of the GAPDH housekeeping gene present on all arrays. 512 EVANS ET AL.
RT 2 Profiler PCR Arrays
RNA extracted from laser-captured mouse uterine tissue (decidualized vs. nondecidualized horns, n ¼ 4 animals, n ¼ 8 arrays) was subjected to pathwayfocused PCR array analysis (product code PAMM-013; SABiosciences) to examine expression of extracellular matrix factors. Initially, genomic DNA contamination was eliminated from the RNA samples by using a genomic DNA elimination kit according to the manufacturer's protocol (SABiosciences). Subsequently, first-strand cDNA synthesis reaction was performed using 150 ng of RNA. RNase free water was added to the cDNA, followed by storage at À208C. A PCR master mixture was prepared using the individual cDNAs and Power SYBR Green Master Mix. The Master Mix (25 ll ) was added to each well of the 96-well array plate, and reactions were run with an Applied Biosystems model 7900 HT-Fast real-time PCR machine at 958C for 10 min with 40 cycles of 15 sec at 958C and 1 min at 608C. Data were analyzed using the data analysis tool provided at www.SABiosciences.com/ pcrarraydataanalysis.php. All data that did not yield detectable signals were removed from analysis. No genomic contamination was noted for any PCR plate. Data from repairing uterine horns were expressed relative to those of control uterine horns (n ¼ 8 individual arrays performed on uterine horns removed 36 h after progesterone removal). Fold changes of .1.3-fold in at least 3/4 animals were considered significant.
Real-Time RT-PCR
To confirm oligonucleotide GEarray data, semiquantitative real-time RT-PCR was performed with RNA across a time course of wound repair from cell line wound healing assays (n ¼ 5). All samples were compared to a standard comparator run on each plate to allow semiquantitative analysis based on final cycle threshold value normalization to the comparator. Cyclic DNA was prepared from 1 lg of RNA, using avian myeloblastosis virus (AMV) reverse transcriptase in a reaction mixture with 53 AMV RT buffer, 10 mM of each deoxyribonucleotide triphosphate, random primers (100 ng/ll), 100 mM dithiothreitol, RNase-out (Invitrogen), and 25 mM MgCl 2 . A total of 100 ng/ml primers for the loading control b-actin or genes of interest (ITGB1, TGFB1, or TIMP1 [ Table 1 ]) were combined in a reaction mixture with cDNA and Power SYBR Green Master Mix and loaded onto an optical reaction plate in duplicate. These were subsequently run on an Applied Biosystems model 7900 HT-Fast real-time PCR machine according to the protocol for SYBR reaction: 508C for 2 min, 958C for 10 min, followed by 40 cycles at 958C for 15 sec, and 608C for 1 min and a dissociation curve to control for nonspecific product formation. Expression of genes of interest were normalized against expression of b-actin.
Immunohistochemistry
Because there was insufficient RNA to confirm expression of ECM factors in mouse uteri as identified by RT 2 Profiler PCR arrays, immunohistochemistry was used to validate the array data. This confirmed translation of mRNA and defined cellular localization of the protein. Immunohistochemistry was also used to determine the expression of ECM factors in normally cycling human endometrium. Briefly, sections fixed in paraffin wax were dewaxed and rehydrated in decreasing concentrations of ethanol. Antigen retrieval was performed by boiling sections in 0.01 M citrate buffer. Endogenous peroxidase activity was blocked by incubation of sections with 3% hydrogen peroxide, followed by blocking of nonspecific binding of antibody by incubation with a solution of 10% nonimmune serum-2% human serum. Primary antibody was applied overnight (ITGB1, 1:200; ITGA5, 1:250; FN1, 1:800; VCAM1, 1:200; mouse neutrophil, 1:100) at 48C. Sections were sequentially washed in 0.2% Tween-Tris-buffered saline and Tris-buffered saline, followed by application of biotinylated secondary antibody at 1:200 for 1 h. This was followed by further wash steps and application of streptavidin-horseradish peroxidase. Application of DAB and counterstaining with hematoxylin enabled visualization of antibody binding. Immunoglobulin G (IgG) controls (goat or rabbit IgG) were included at the same final concentrations as that of the primary antibody and showed no staining. Sections were then dehydrated through increasing concentrations of ethanol and histosol prior to being mounted with DPX. Pairs of same animal controls and repairing horns from five individual animals were examined. Samples of human endometrium with visible luminal epithelium taken immediately prior to menstruation (late secretory, n ¼ 3), during menstruation (D1-D3 of menstrual cycle, n ¼ 10), and in the early stages of postmenstrual repair (D4-D6 of menstrual cycle, n ¼ 10) were examined.
Statistical Analysis
All statistical analyses were performed using PRISM version 4.03 software for Windows (Graphpad). All data were tested for normality prior to analysis. In the case of normally distributed data, an unpaired t-test was performed. In the case of non-normally distributed data, a Mann-Whitney test was performed. A P value of 0.05 was considered significant. All data are presented as mean 6 SEM.
RESULTS
Expression of ECM Genes in Actively Repairing Mouse Endometrium
A menstruation event was induced in mouse uteri that mimicked menstrual breakdown. At 24 h after progesterone implant removal, in control horns, it can be seen that the endometrium is intact (Fig. 1A) , whereas in uterine horns where decidualization was induced, progesterone removal leads to endometrial breakdown and shedding (Fig. 1B) . Paired control and repairing uterine horns were harvested from each animal, and luminal epithelia and subluminal stroma were laser-captured (n ¼ 4 animals in total). In control horns, the luminal epithelium (Fig. 1C, open arrowhead) and stroma remained intact, whereas in those undergoing active repair, the luminal epithelium (Fig. 1D , open arrowhead) was flattened and less columnar. These uterine horns were actively repairing, with areas yet to undergo re-epithelialization (Fig. 1D , closed arrowhead). Figure 1 , E and F, indicates areas of repairing endometrium before and after laser capture microdissection. Using the laser-capture software, a line indicates areas at which the laser should cut (black line, Fig. 1E ; open arrowhead indicates luminal epithelium to be cut; closed arrowhead indicates subluminal stroma to be cut). Subsequent to laser firing, microdissected areas were catapulted off the slide by laser firing and collected for downstream processing. The luminal epithelium and immediate subluminal stroma were specifically catapulted for collection and can no longer be seen in Figure 1F . Due to variations in the temporal progress of repair, somewhat different stages of repair are observed in different animals and different areas of each uterine horn, contributing to the variability seen when using this model [21] .
Transcript abundance of basement membrane components were !1.3-fold elevated during murine endometrial repair, including a number of collagen (Col3a1, Col4a1, Col4a2, Col5a1) Ecm1 and Fn1 isoforms (Fig. 1G) . The Lama3 abundance was suppressed (Fig. 1K) . Additionally, mRNA transcript abundance of a number of proteases was increased, including members of the ''a disintegrin and metalloproteinase with thrombospondin motifs'' (Adamts2, Adamts5, and Adamts8) and matrix metalloprotease (MMPs; Mmp9, Mmp11, and Mmp15) families of proteases, along with the Timp3 tissue inhibitor of MMPs (Fig. 1H) , whereas Adamts1 mRNA was down-regulated in the repairing endometria (Fig. 1K) .
Integrin subunits also displayed elevated transcript abundance during repair; including Itga4 and Itga5 mRNA, which form heterodimers with the similarly elevated Itgb1 subunit. Other integrin subunits elevated in the repairing mouse endometria, Itgal, Itgam, and Itgax, are expressed on leukocytes and form heterodimers with the up-regulated Itgb2 TGFB1 Reverse
ECM DYNAMICS IN ENDOMETRIAL REPAIR subunit (Fig. 1I ). Certain ECM factors that can act as ligands for these integrin heterodimers, including Vcam1 and intercellular adhesion molecule (Icam1), also displayed elevated transcript abundance in the repairing mouse endometria (Fig.  1J) . Furthermore, Cd44, Sell (L-selectin), Sgce (sarcoglycanepsilon), Sparc (secreted protein acidic and rich in cysteine), and Thbs2 (thrombospondin2) transcripts were substantially increased (Fig. 1J) , with Fbln1 (fibulin 1) expression downregulated (Fig. 1K) .
Expression of ECM Genes in an In Vitro Model of Endometrial Repair
Following wounding of monolayers of ECC-1 cells in a 96-well plate, RNA was extracted from repairing monolayers immediately (D0) and every day following for 6 days. On Days 0, 1, 2, and 5 (D0-D5), RNA was used to examine differential expression of ECM genes across a time course of endometrial repair by pathway-focused array (n ¼ 6 pooled). These days represent the initial stages of repair, when re-epithelialization in vitro is proceeding most quickly in comparison with the end stages of repair on D5. Figure 2A represents the typical appearance of a wounded monolayer on D0. By D2, the area of the wound is reduced compared with that on D0 (Fig. 2B) ; by D5, the wound has undergone almost complete re-epithelialization (Fig. 2C) .
Gene array analysis demonstrated that the ADAMTS1 gene displays increased transcript abundance by D1, in contrast to that observed in the mouse model, and remains at this level throughout repair. While undetectable on D0, both MMP2 and MMP10 transcripts demonstrate some elevation by D1 but do not change further across the time course of re-epithelialization. TIMP1 transcript abundance markedly increases throughout the time course to achieve maximal expression by D5 of reepithelialization (Fig. 2D) .
Transcripts of integrin subunits are also differentially regulated across the time course of re-epithelialization (Fig.  2E) . In particular, on D1 of repair, the ITGA3 gene is expressed. On D2 and D5 of repair, the ITGA5 gene is expressed and displays abundance on D5 that is increased compared with that
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on D2. The ITGB1 gene is maintained, and expression is substantially elevated from D1 to D5 of repair (Fig. 2E) .
TGFB1 growth factor is not detected on D1 of reepithelialization, but its transcript is expressed and elevated on D2 and D5 (Fig. 1F) . SGCE transcript abundance dramatically increases from D0 to D2, followed by a modest drop in expression by D5, while the TNC (tenascin) gene shows a modest increase in transcript abundance on D2 and D5 (Fig. 1F) .
A number of collagen and laminin isoforms are also expressed across the time course of repair in the ECC-1 cells. The COL12A1, COL6A1, and LAMA5 genes display similar patterns of expression, with continuing increases in transcript abundance from D1 to D5, while others including the COL18A1, LAMB1, and LAMC1 genes demonstrate differential patterns, with an initial increase on D1-D2, followed by a decrease in abundance (Fig. 2G ). CTNNA1 and CTNNB1 transcript abundance levels increase across the time course of wound repair, while CTNND1 abundance is elevated on D1 only (Fig. 2H) .
To confirm these array data examining re-epithelialization in vitro, a number of genes were chosen for quantitative real-time RT-PCR validation. These genes were chosen based on the magnitude of their changes in expression observed across the time course of repair. Expression of ITGB1 (Fig. 3A) , TGFB1 (Fig. 3B) , and TIMP1 (Fig. 3C ) mRNA levels increased across a time course of repair in ECC-1 cells (n ¼ 5), with significantly higher expression observed on D5 of repair than on D1 (P , 0.05) in accord with gene array data.
Localization of ECM, Adhesion Proteins, and Neutrophils in Repairing Murine Endometria
To confirm translation of mRNA and localization of ECM and related proteins in the repairing mouse endometria, immunohistochemical staining was performed for FN1, VCAM1, ITGA5, and ITGB1 protein in animals culled at 48 h, when endometrial repair is nearly complete. Additionally, due to array identification of integrins reported to be present on leukocytes, the localization of neutrophils was also determined. Immunoreactive ITGA5 localized to the glandular and luminal epithelial cells consistently in the repairing uterine horns (Fig. 4F) and variably in the nonrepairing uterine horns (Fig. 4E) . ITGA5 immunostaining was most intense at the actual sites of repair. Similarly, ITGB1 staining was faint in nonrepairing uterine horns, with the exception of blood vessels (Fig. 4G) . In contrast, ITGB1 strongly immunolocalized to the luminal epithelium of all uterine horns undergoing repair (open arrow, Fig. 4H ) and to single cells present in the subluminal stroma, most likely leukocytes (white arrowhead, Fig. 4H ).
Neutrophils were present in high numbers within the repairing uterine horn, with many in intimate association with the repairing luminal epithelium (closed arrow, Fig. 4J ). Very few neutrophils were noted in the control horns, and these were not clustered or associated with any specific cellular compartment (closed arrow, Fig. 4I ). Close examination of immunostaining for ITGB1 (Fig.  4K) and neutrophils (Fig. 4L ) in serial sections of repairing murine endometria revealed ITGB1 was localized to the cell surface of neutrophils (closed arrows, Fig. 4 , K and L).
Localization of VCAM1 and ITGB1 in Repairing Human Endometrium
During late secretory phase, immediately prior to menstruation (n ¼ 3), little VCAM1 staining was observed, with the exception of limited immunoreactivity on the apical edges of some luminal epithelial cells (arrows, Fig. 5A ) and localization to blood vessels (arrowhead, Fig. 5A ). Strong staining was present in blood vessels in samples taken on D1 (n ¼ 4) of the menstrual cycle (Fig. 5B) , while strong staining for VCAM1 was observed in repairing surface epithelium of endometrial samples removed on D2 (arrow, Fig. 5C [n¼3]) and D3 (arrows, Fig. 5 , D and E [n ¼ 3]) of menstrual bleeding. However, VCAM1 staining was not observed in the residual gland stumps from which the cells actively participating in repair are proposed to arise (arrow, Fig. 5F ) [9] . By D5 (Fig.  5G [n ¼ 4]) and D6 (Fig. 5H [n ¼ 4] ), when postmenstrual reepithelialization is complete, expression of VCAM1 in the newly formed luminal epithelium was either patchy or absent. Thus, VCAM1 is localized to luminal epithelium only during active repair.
ITGB1 expression is limited to the luminal epithelium of the late secretory endometrium, with only faint staining observed (Fig. 5I) , whereas ITGB1 staining is absent from the luminal epithelium on the first day of menstrual bleeding, with limited expression localized to decidualized stroma (Fig.  5J) . On D3 of menstrual bleeding, when active repair is taking place, strong ITGB1 staining localized to the repairing luminal epithelium, with some immunoreactivity also observed in the glandular epithelium (Fig. 5K ). On D5 (Fig. 5L) and D6 (Fig. 5, M, N, and O) , when re-epithelialization is almost complete, ITGB1 expression becomes patchy, as noted for VCAM1, with expression localized to areas that are presumably still repairing (Fig. 5N) , and limited staining was evident in the residual gland stumps from which the cells are migrating (Fig. 5O) . Staining for ITGB1 was observed in glandular epithelium (data not shown). As observed for VCAM1, ITGB1 localizes to luminal epithelium during active repair.
Functional Significance of Integrin and Protease Expression During Endometrial Re-epithelialization
To determine the functional significance of a role for integrin-fibronectin binding in endometrial repair, in vitro wound-healing assays were performed in the presence of RGD integrin-binding peptides. RGE peptides represent a modified RGD sequence with low affinity for integrins, used here as a control. Addition of RGD peptides significantly inhibited the extent of repair of wounds created in the ECC-1 monolayers on   FIG. 3 . Validation of ECM changes across a time course of wound repair are shown. A) ITGB1 expression increased across the time course to peak on D5. B) TGFB1 expression increased across the time course to peak on D6. C) TIMP1 expression increased across the time course to peak on D6. Data are presented as mean fold changes from D0 6 SEM (*, P , 0.05, n ¼ 5).
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all days across the time course of repair compared with that of vehicle control or RGE-treated wounds (Fig. 6A, P , 0.001) . The low-affinity RGE peptide sequence had no effect on the extent of repair of wounded ECC-1 monolayers (Fig. 6A, P . 
0.05).
To determine the functional importance of proteases in endometrial repair, in vitro wound-healing assays were performed in the presence of a broad-spectrum-based MMP inhibitor, doxycycline [21] , and a more specific MMP inhibitor, GM6001. Treatment of wounded ECC-1 mono- ECM DYNAMICS IN ENDOMETRIAL REPAIR 517 layers with 0.5 lg/ml or 2.5 lg/ml doxycycline dosedependently reduced the extent of repair on all days across the time course of repair (Fig. 6B, *P , 0 .05, **P , 0.01). In contrast, treatment of wounded ECC-1 monolayers with 20 lM (Fig. 6C) or 25 lM (Fig. 6D) GM6001 slowed the extent of wound repair only on D1 and D2 of the time course of repair ( Fig. 6C, P , 0.05; Fig. 6D , respectively, P , 0.001) but had no effect on the extent of repair after D3.
DISCUSSION
The molecular mechanisms underlying scar-free repair of the endometrium after menstruation are little understood. Using (closed arrow, B) . On D2 of the menstrual cycle, VCAM1 localized to gland stumps (closed arrow, C) and epithelial cells arising from the gland stumps (open arrow, C). On D3, immunoreactive VCAM1 localized to stroma and luminal epithelium (closed arrows D). Enclosed black box demonstrates expression of VCAM1 in luminal epithelium (closed arrow, E). Enclosed dashed line box demonstrates VCAM1 in luminal epithelium but not at the base of gland stumps (closed arrow, F). D5, VCAM expression is patchy (closed arrow vs. open arrow, G), whereas on D6 of the menstrual cycle, VCAM expression is absent from luminal epithelium (closed arrow, H). On D26, faint ITGB1 staining localized to the luminal epithelium (closed arrow, I). On the first day of menstrual bleeding, ITGB1 expression localizes to the stroma but not luminal epithelium (closed arrow, J). On D3 of the menstrual cycle, immunoreactive ITGB1 strongly localized to luminal epithelium (closed arrow, K) with immunoreactivity also localized to blood vessels (closed arrowhead, K). On D5, ITGB1 expression is patchy (closed arrow vs. open arrow, L). On D6 of the menstrual cycle, ITGB1 expression localized to the luminal epithelium (closed arrows, M) and some stromal cells. Enclosed black box demonstrates expression of ITGB1 in some areas of luminal epithelium (closed arrow, N). Enclosed dashed line box demonstrates ITGB1 expression does not immunolocalize to the base of gland stumps (closed arrow, O). Appropriate IgG-matched negative controls are shown as insets in A and I. Images in B, D, M and negative controls (insets in A and I) were taken at an original magnification of 340. All other images taken at an original magnification of 3100.
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both an in vitro human model and an in vivo mouse model, along with immunolocalization studies of carefully timed human curettage material, we demonstrate specific changes in ECM, cell adhesion, and protease molecules at the sites of endometrial re-epithelialization and confirm the importance of integrin-fibronectin interactions and MMP activity by using functional studies. By comparison with published data, it is evident that differences exist in the expression and potential roles of integrins, the TGF-b superfamily, MMPs, and the innate immune system in endometrial scar-free repair compared with scarring dermal wounds.
As in other repair processes, such as models of intestinal repair [22] , cell migration is essential during the initial reepithelialization stage of endometrial repair [23] . Classical histology and scanning electron microscopy studies [9, 10, 23] have shown that the epithelial cells in residual gland stumps and areas adjacent to the denuded surface spread over the depleted functionalis, initiating re-epithelialization in the absence of proliferation [23] . For spreading and cell movement to occur, a provisional matrix is required to provide traction for migrating cells in addition to dynamic alterations in the ECM and related molecules of the migrating cells themselves. This study aimed to define those dynamic changes during endometrial re-epithelialization.
Due to the difficulties in examining a tissue undergoing simultaneous destruction and repair [8] , we used both an in vitro human model of re-epithelialization, utilizing endometrial luminal epithelial cells (ECC-1), and an in vivo murine model of induced endometrial breakdown and repair. These models provided key information about endometrial re-epithelialization from different perspectives. The in vitro model allowed examination of ECM dynamics specifically in epithelial cells over a time course of repair approximating the time required for re-epithelialization in the human endometrium. The ECC-1 wounding assays for array analysis were performed in 96-well plates in which the wound represented a high percentage of the total surface, avoiding dilution of the effects at the wound edge. The in vivo murine model of menstruation and repair provided information about the dynamic interactions among the epithelium, stroma, leukocytes, and their ECM during FIG. 6 . Functional investigation of ECM factors in re-epithelialization using an in vitro model of endometrial repair is shown. A) A 25 lM RGDS (n) but not 25 lM RGES (m) significantly inhibited the extent of re-epithelialization compared with that of control (¤). B) Concentrations of 0.5 lg/ml doxycycline (n) and 2.5 lg/ml doxycycline (m) significantly inhibited the extent of re-epithelialization compared with that of control (¤). Incubation with 20 lM GM6001 (C, n) or 25 lM GM6001 (D, n) significantly inhibited the extent of re-epithelialization on D1 (C, D) and D2 (D) compared with control (¤). All data are expressed as mean percentage of repair 6 SEM, combined data from n ! 4 individual experiments. *, P , 0.05; **, P , 0.01; ***, P , 0.001.
ECM DYNAMICS IN ENDOMETRIAL REPAIR
endometrial repair. Laser-captured microdissection was performed on the uterine horns to specifically examine repairing surfaces, namely the epithelium and underlying stromal compartment. Thus, both models enabled demonstration of dynamic ECM changes specifically in the wound area during re-epithelialization.
Basement Membrane
Transcript abundance of a number of procollagens was elevated in both the mouse model and the ECC-1 cell line during repair. Procollagens must be processed to collagen by MMPs and ADAMTS before they can form part of the extracellular matrix [24] . Expression of procollagens and processing enzymes during repair in the ECC-1 model may imply that these cells lay down an extracellular matrix during re-epithelialization, providing traction for cell movement. In the mouse model, Adamts2 expression corresponded with Col3A1 expression, which it converts to mature collagen [25] . However, Timp3, an inhibitor of this conversion system, is also elevated in the mouse model, suggesting that a fine balance between these factors is important in collagen deposition during endometrial repair [26] . There is also evidence that appropriate expression of collagen IV in the basement membrane is dependent on Sparc expression [27] , both of which demonstrated elevated transcript abundance during repair in the mouse model. In confirmation of our data, a number of collagen mRNAs, including COL12A1 and COL18A1 transcript levels, were elevated in areas of human endometrium isolated by laser capture that were undergoing tissue destruction at the time of menstruation and presumably preparing for repair [28] .
Fn1 expression is elevated only in the mouse model of repair, and immunohistochemistry confirmed its subluminal localization in repairing uteri. This observation is partly in contrast to that reported during endometrial repair in a rhesus macaque model [16] . While FN1 mRNA was elevated during postmenstrual repair, as in our study, immunoreactive FN1 was localized to the endometrial epithelial cells in contrast to the stromal expression observed herein. This may be due to species differences or may result from the use of different antibodies with epitope specificities for different forms of FN1.
Integrins
Other factors reported as elevated in the repairing rhesus macaque endometrium, and in accord with our studies, include the ITGA3, ITGA5, and ITGB1 integrins [16] . Both ITGA5 and ITGB1 immunolocalize to the luminal epithelium in all three models (human, mouse, and rhesus macaque) (12) . Additionally, ITGA2B subunits were elevated in lysed areas of human endometrium [28] , again in concordance with our studies. Importantly, ITGA3 and ITGA5 expression levels are not elevated in dermal wounds that scar [29] . Indeed, during skin re-epithelialization, integrin a3b1 heterodimer is proposed to inhibit cell migration [30] , whereas this heterodimer is required for endometrial re-epithelialization. The integrin heterodimer a3b1 plays a role in formation of lamellae and in MMP expression and is elevated in early stages of intestinal repair, acting as a migratory integrin [22, [31] [32] [33] . It forms a cellular receptor for LAMA5 [29] and COL6 [34] , which are similarly expressed in the ECC-1 and mouse models, suggesting adhesion to laminin and collagens is important in the early migration stages of repair and lamellae formation in this nonscarring re-epithelialization. The integrin a5b1 heterodimer is involved in the epithelial migration at the leading edges of wounds [29, 35] . However, the integrin a5b1 heterodimer is also proposed to play a role in the permanent adhesion associated with the end stages of repair [36] . This and a3b1 form receptors for FN1 [37] . ITGA2B expression, identified in both the current study and that of Gaide Chevronnay et al. [28] , is proposed to influence cellular behavior and tissue remodeling by its actions in mediating synthesis of collagen and protease expression.
Functionally, addition of RGDS peptide (blocking the RGD motif, the most important recognition site for approximately half of all known integrins [38] ) to wounded ECC-1 monolayers significantly and specifically inhibited the extent of re-epithelialization. These results suggest that locomotion on fibronectin is important for endometrial re-epithelialization. It is anticipated that the interactions between subluminal fibronectin and epithelial integrins are also required in vivo, mediating signaling for cell migration, differentiation, and growth. This is illustrated in Figure 7 , where the proposed dynamic interactions between integrins and their ligands during endometrial repair are shown.
A number of other integrins that display elevated transcript abundance exclusively in the repairing mouse endometrium include those expressed on leukocytes. In this model, we have previously demonstrated that neutrophils are functionally important for endometrial repair [39] . Integrin heterodimers a4b1 (VLA-4) and aLb2 (LFA-1) are expressed on neutrophils, which are closely associated with the luminal epithelium in re-epithelializing areas [39] . We have shown here in the mouse model that some ITGB1-expressing cells in close proximity to the repairing luminal epithelium are neutrophils, likely expressing the a4b1 heterodimer (Fig. 4) .
Cellular Adhesion Molecules
If the presence of cells of the innate immune system in the endometrium is important for repair, how do these cells ''know'' where to mediate their actions? In blood vessels, leukocytes bind to ligands including VCAM1 and ICAM1 via the integrin heterodimer a4b1 [40, 41] , the same ligands and integrins that are elevated in the repairing uterine horn of the mouse model. Importantly, in the repairing uterine horns we observed strong VCAM1 staining of the luminal epithelium. A similar pattern of VCAM1 localization to the repairing luminal epithelium can be observed in human endometrial tissue samples. Importantly, the VCAM knockout mouse displays delayed cutaneous repair in association with a reduced inflammatory response [42] . The localization of ITGB1 on neutrophils closely associated with VCAM1-expressing luminal epithelium suggests a novel mechanism by which leukocytes may ''home'' to the luminal epithelium to participate in repair. This intimate interaction of neutrophils with the re-epithelializing luminal epithelium and the potential of VCAM1 as a homing mechanism for these inflammatory cells are shown in Figure 7 .
Proteases
Proteases are required to facilitate the locomotion of cells during re-epithelialization. Certain MMPs and ADAMTS display increased transcript abundance during re-epithelialization in the ECC-1 cell line model and the mouse model, while some of the same MMPs and TIMPs (MMP9 and MMP10 and TIMP1 and TIMP3) are also elevated in lysed areas of the human endometrium isolated by laser capture from menstrual endometrium [28] . Although these studies demonstrate common factors, the human endometrial samples used in the study 520 by Gaide Chevronnay et al. [28] were taken at the initiation of menstruation at the time of tissue destruction, while our study examined the repairing endometrium. However, because these repair processes take place concurrently, it is likely that some of the same factors are important for both events. The factors involved in endometrial repair again present some contrasts with those in scarring dermal wound repair. Expression of MMPs including MMP9 are down-regulated during early dermal responses to injury, with elevation subsequently observed for MMP2, MMP9, and MMP11 in the late phase of repair [43, 44] . These MMPs, however, are elevated in the active early stages of repair in both our in vivo and in vitro models. These differences may relate to the time scale of repair, with rapid endometrial re-epithelialization typically taking place within 48 h compared with a number of weeks for dermal re-epithelialization.
In our cell line model, application of MMP inhibitors significantly inhibited re-epithelialization in the earliest stages of repair, in contrast to previous studies in our mouse model in which inhibition of MMP activity did not retard endometrial repair [21] . This discrepancy between the models may be related to the specific inhibition of re-epithelialization by MMP inhibitors. In the mouse model, where additional cell types are present, there may be compensatory mechanisms including additional redundancy to preserve endometrial function essential for reproduction or natural inhibitors of stromal origin. However the MMP inhibitor (GM6001) used herein and in the previous study [21] inhibits only MMP1, MMP2, MMP3, MMP8, and MMP9 [45] , whereas MMP10 was elevated in our cell line model of re-epithelialization, and MMP11 and MMP15 were elevated in the mouse model. Their activity levels would not be affected by the inhibitor. Other proteases including the ADAMTS family may remain functional when MMPs are inhibited. Because MMPs and ADAMTS proteases have substrate specificities that will be governed by the local microenvironment and because proteases do not act alone, it is difficult to determine the direct role of a specific protease in any complex system [46] .
Growth Factors
One situation of scar-free repair that may present parallels with endometrial repair is that of regenerative limb repair in axolotls. This repair, including the initial re-epithelialization of the wound site, is to some degree dependent on expression of TGFB; inhibition of TGFB slows initial re-epithelialization of the wound and subsequent limb regeneration [47] . In normal skin wounds, TGFB expression slows repair and contributes to scarring [3, 48] . In contrast, in our ECC-1 model of endometrial re-epithelialization, TGFB expression is elevated across a time course of repair, which may correspond to a role in elevating protease expression, protease-inhibitors, and fibronectin-binding integrins, specifically ITGB1 and ADAMTS2 [49] . Additionally, activin A, a member of the TGFB superfamily, is important in tissue repair [17] : in mice overexpressing the activin antagonist, follistatin, endometrial repair was retarded following endometrial breakdown. It is thus possible that downstream signaling, gene expression, or protein activation mediated by members of the TGFB superfamily may be different in scarring versus scar-free wounds.
Summary
The cyclic scar-free repair observed in the endometrium is unlikely to be due solely to changes in expression of the ECM and related factors examined in this study, as repair results from a wide range of biological interactions and signaling events coordinated over the time course of repair. There are doubtless changes in production of growth factors, chemokines, and cytokines that contribute to endometrial repair and possibly govern ECM interactions. Indeed, the present study complements that of Gaide Chevronnay et al. [28] , which focused on degrading endometrium. The number of concordant genes between the two studies strengthens the concept that similar factors participate simultaneously in destruction and repair in this tissue. As the endometrium is the only tissue undergoing this programmed shedding and repair, it is not possible to compare these data directly with conventional repair models, despite a number of common features.
Only a global definition of the changes taking place in this remarkable tissue during re-epithelialization will provide greater insight into the process of scar-free endometrial repair. Once we understand the ''normal'' endometrial repair process, we will be able to examine how this may be altered under pathological conditions. It is likely that menorrhagia associated with menstrual bleeding of long duration may result from defects in repair mechanisms and that breakthrough bleeding such as that seen with the use of long-term progestin-only contraceptives [50] may be enabled by fragile epithelium resulting from inadequate repair. Such information will assist in developing better diagnoses and treatments for these conditions. Although these data focus on the endometrium, it is likely that understanding scar-free endometrial repair will have applications to regenerative repair in other tissues. Scarfree repair is the ''holy grail'' for those working in the field of wound healing. Examination of the repairing endometrium   FIG. 7 . Suggested ECM interactions mediating endometrial re-epithelialization upon migration of epithelial cells from residual endometrial gland stumps within denuded endometrial surface are shown. We suggest that initial interactions of a3b1 integrin with laminins, fibronectin, and collagens take place as the endometrial epithelial cells migrate. As these cells become adhered, firm interactions between fibronectin and a5b1 integrins take precedence. The interaction of neutrophils via their surface integrins with epithelial adhesion molecules including VCAM1 and ICAM1 is proposed as a novel mechanism essential in endometrial re-epithelialization.
presents a unique opportunity to determine repair mechanisms in a nonscarring adult human tissue, which may be more relevant to adult wound healing than drawing parallels with fetal or amphibian repair. It is anticipated that enhanced understanding of these mechanisms may enable development of treatments to reduce scarring and its associated loss of function.
